Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07290517 · ClinicalTrials.gov registry record · NA

Assessing Pain and Effectiveness of Carevix Device for IUD Insertions

A NA study, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target

NCT07290517: Recruiting NA study, sponsored by Indiana University.

NCT07290517 is a NA study that is actively recruiting participants, run by Indiana University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07290517, a NA study, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The goal of this clinical trial is to evaluate patient-reported pain, bleeding, and device efficiency along with provider satisfaction and ease of use between IUD insertions using a suction cervical stabilizer (new device, FDA approved, atraumatic) and single-tooth tenaculum (standard, traumatic). Our aims are to: * assess and compare patient-reported pain during IUD insertion between the Carevix device and tenaculum. * assess predictors of pain scores including between nulliparous and multiparous patients * assess provider-reported ease of use and satisfaction Participants (including providers) will: * be randomized to receive one device to complete the IUD procedure * complete a survey following the procedure

Primary Outcome

Participants will be asked to rate their pain prior to, during, and after the IUD insertion procedure on a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable."

Interventions

  • DEVICE Carevix
  • DEVICE Tenaculum

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-03-11
Est. Completion 2027-03
Phase NA
Indiana University

890 total trials

What NCT07290517 shows while recruiting

NCT07290517 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Carevix is the first listed.

NCT07290517 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07290517 about?

NCT07290517 is a clinical study titled "Assessing Pain and Effectiveness of Carevix Device for IUD Insertions". The goal of this clinical trial is to evaluate patient-reported pain, bleeding, and device efficiency along with provider satisfaction and ease of use between IUD insertions using a suction cervical stabilizer (new device, FDA approved, atraumatic) and single-tooth tenaculum (standard, traumatic). O...

What is the current status of trial NCT07290517?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-03-11. Estimated completion is 2027-03.

What interventions are being tested in trial NCT07290517?

The interventions under investigation include: Carevix (DEVICE), Tenaculum (DEVICE).

Who is sponsoring clinical trial NCT07290517?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07290517's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07290517, the US trial registry maintained by the National Library of Medicine. NCT07290517 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.